Bosh sahifaBICO • STO
add
BICO Group AB
Yopilish kursi
23,42 kr
Kunlik diapazon
22,82 kr - 23,72 kr
Yillik diapazon
22,40 kr - 56,55 kr
Bozor kapitalizatsiyasi
1,58 mlrd SEK
Oʻrtacha hajm
451,78 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
CNBC
20 soat oldin
S&P 500 fights for another record — plus, Eaton signals big data center opportunity
0,048%
1,62%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 324,20 mln | -23,41% |
Joriy xarajat | 247,90 mln | -8,59% |
Sof foyda | -184,20 mln | -136,46% |
Sof foyda marjasi | -56,82 | -208,80% |
Har bir ulushga tushum | — | — |
EBITDA | -44,30 mln | -360,59% |
Amaldagi soliq stavkasi | -0,72% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 636,30 mln | -7,46% |
Jami aktivlari | 4,55 mlrd | -20,14% |
Jami passivlari | 2,08 mlrd | -23,45% |
Umumiy kapital | 2,46 mlrd | — |
Tarqatilgan aksiyalar | 70,57 mln | — |
Narxi/balansdagi bahosi | 0,68 | — |
Aktivlardan daromad | -5,68% | — |
Kapitaldan daromad | -6,64% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -184,20 mln | -136,46% |
Operatsiyalardan naqd pul | -28,20 mln | 44,60% |
Sarmoyadan naqd pul | -3,90 mln | 82,74% |
Moliyadan naqd pul | -21,90 mln | 21,22% |
Naqd pulning sof oʻzgarishi | -40,40 mln | 62,63% |
Boʻsh pul | -3,09 mln | 98,48% |
Haqida
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Tashkil etilgan
27-yan, 2016
Sayt
Xodimlar soni
602
